1. PBX1: a TALE of two seasons—key roles during development and in cancer
    Laura Crisafulli et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
  2. HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survival
    Saqlain Suleman et al, 2022, Gene Therapy CrossRef
  3. PBX1: a key character of the hallmarks of cancer
    Rafaela Nasser Veiga et al, 2021, Journal of Molecular Medicine CrossRef
  4. FOXO3a in cancer drug resistance
    Ying Liu et al, 2022, Cancer Letters CrossRef
  5. Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer
    Ying Liu et al, 2022, Molecular Therapy - Nucleic Acids CrossRef
  6. The FOXO family of transcription factors: key molecular players in gastric cancer
    Ying Liu et al, 2022, Journal of Molecular Medicine CrossRef
  7. FADD as a key molecular player in cancer progression
    Ying Liu et al, 2022, Molecular Medicine CrossRef
  8. The regulation of PBXs and their emerging role in cancer
    Ying Liu et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
  9. PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications
    Ting-Wan Kao et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  10. PBX1 attenuates 6-OHDA-induced oxidative stress and apoptosis and affects PINK1/PARKIN expression in dopaminergic neurons via FOXA1
    Binglong Li et al, 2022, Cytotechnology CrossRef
  11. Emerging role of pioneer transcription factors in targeted ERα positive breast cancer
    Honey Pavithran et al, 2021, Exploration of Targeted Anti-tumor Therapy CrossRef
  12. Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
    Ying Liu et al, 2021, Frontiers in Oncology CrossRef
  13. Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis
    Chao Cheng et al, 2023, Journal of Thoracic Oncology CrossRef
  14. PBX1-promoted SFRP4 transcription inhibits cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma
    Liwen Guo et al, 2023, Tissue and Cell CrossRef
  15. Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
    Ying Liu et al, 2022, Frontiers in Oncology CrossRef
  16. PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors
    Yinxu Wan et al, 2022, Current Cancer Drug Targets CrossRef
  17. Correlation analysis of PBX family with immune invasion and drug sensitivity in colon adenocarcinoma
    Guanqun Chao et al, 2023, Heliyon CrossRef
  18. Identification of ZG16B as a prognostic biomarker in breast cancer
    Haotian Lu et al, 2020, Open Medicine CrossRef
  19. A radiogenomics application for prognostic profiling of endometrial cancer
    Erling A. Hoivik et al, 2021, Communications Biology CrossRef
  20. The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer
    Atousa Ghorbani et al, 2024, Cancer Genetics CrossRef
  21. Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer
    Ying Liu et al, 2021, Molecular Therapy - Oncolytics CrossRef
  22. Mechanistic Targets of Diallyl Trisulfide in Human Breast Cancer Cells Identified by RNA-seq Analysis
    Eun-Ryeong Hahm et al, 2021, Journal of Cancer Prevention CrossRef
  23. A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis
    Saioa Mendaza et al, 2021, Biomedicines CrossRef
  24. Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression
    Ying Liu et al, 2022, Journal of Molecular Medicine CrossRef